| Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# MH Abdul-Aziz, JC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ... Intensive Care Med 46 (6), 1127-1153, 2020 | 805* | 2020 |
| From therapeutic drug monitoring to model‐informed precision dosing for antibiotics SG Wicha, AG Märtson, EI Nielsen, BCP Koch, LE Friberg, JW Alffenaar, ... Clinical Pharmacology & Therapeutics 109 (4), 928-941, 2021 | 206* | 2021 |
| Towards precision dosing of vancomycin: A systematic evaluation of pharmacometric models for Bayesian forecasting A Broeker, M Nardecchia, KP Klinker, H Derendorf, RO Day, DJ Marriott, ... Clinical Microbiology and Infection, 2019 | 142 | 2019 |
| A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions SG Wicha, C Chen, O Clewe, USH Simonsson Nature communications 8, 2129, 2017 | 126 | 2017 |
| TDMx: a novel web-based open-access support tool for optimising antimicrobial dosing regimens in clinical routine SG Wicha, MG Kees, A Solms, IK Minichmayr, A Kratzer, C Kloft International Journal of Antimicrobial Agents 45 (4), 442-444, 2015 | 82 | 2015 |
| A model averaging/selection approach improves the predictive performance of model‐informed precision dosing: vancomycin as a case study DW Uster, SL Stocker, JE Carland, J Brett, D JE Marriott, RO Day, ... Clinical Pharmacology & Therapeutics 109 (1), 175-183, 2021 | 70 | 2021 |
| Unbound fraction of vancomycin in intensive care unit patients MG Kees, SG Wicha, A Seefeld, F Kees, C Kloft The Journal of Clinical Pharmacology 54 (3), 318-323, 2014 | 68 | 2014 |
| Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus SG Wicha, MG Kees, J Kuss, C Kloft Pharmaceutical Research 32, 2410-2418, 2015 | 58 | 2015 |
| Machine learning and pharmacometrics for prediction of pharmacokinetic data: differences, similarities and challenges illustrated with rifampicin L Keutzer, H You, A Farnoud, J Nyberg, SG Wicha, G Maher-Edwards, ... Pharmaceutics 14 (8), 1530, 2022 | 57 | 2022 |
| Mobile health apps for improvement of tuberculosis treatment: descriptive review L Keutzer, SG Wicha, USH Simonsson JMIR mHealth and uHealth 8 (4), e17246, 2020 | 53 | 2020 |
| Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients MG Kees, IK Minichmayr, S Moritz, S Beck, SG Wicha, F Kees, C Kloft, ... The Journal of Clinical Pharmacology 56 (3), 307-315, 2016 | 50 | 2016 |
| Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients CB Cunio, DW Uster, JE Carland, H Buscher, Z Liu, J Brett, M Stefani, ... Clinical Microbiology and Infection 27 (5), 783. e7-783. e14, 2021 | 49 | 2021 |
| Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study A Broeker, SG Wicha, C Dorn, A Kratzer, M Schleibinger, F Kees, ... Critical care 22, 1-7, 2018 | 47 | 2018 |
| How to design a study to evaluate therapeutic drug monitoring in infectious diseases? AG Märtson, MGG Sturkenboom, J Stojanova, D Cattaneo, W Hope, ... Clinical Microbiology and Infection 26 (8), 1008-1016, 2020 | 44 | 2020 |
| Simultaneous determination and stability studies of linezolid, meropenem and vancomycin in bacterial growth medium by high-performance liquid chromatography SG Wicha, C Kloft Journal of Chromatography B 1028, 242-248, 2016 | 43 | 2016 |
| Impact of inaccurate documentation of sampling and infusion time in model-informed precision dosing D Alihodzic, A Broeker, M Baehr, S Kluge, C Langebrake, SG Wicha Frontiers in Pharmacology 11, 172, 2020 | 41 | 2020 |
| Linezolid in liver failure: exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot study SG Wicha, OR Frey, AC Roehr, J Pratschke, M Stockmann, R Alraish, ... International Journal of Antimicrobial Agents 50 (4), 557-563, 2017 | 38 | 2017 |
| Research priorities towards precision antibiotic therapy to improve patient care ZP Bulman, SG Wicha, EI Nielsen, JR Lenhard, RL Nation, ... The Lancet Microbe 3 (10), e795-e802, 2022 | 37 | 2022 |
| A machine learning approach to predict interdose vancomycin exposure M Bououda, DW Uster, E Sidorov, M Labriffe, P Marquet, SG Wicha, ... Pharmaceutical Research 39 (4), 721-731, 2022 | 37 | 2022 |
| Unbound fraction of ertapenem in intensive care unit patients U Liebchen, A Kratzer, SG Wicha, F Kees, C Kloft, MG Kees Journal of Antimicrobial Chemotherapy 69 (11), 3108-3111, 2014 | 37 | 2014 |
Johannes AlffenaarEmail confirmado em sydney.edu.au
